D J Triulzi

Summary

Affiliation: University of Pittsburgh
Country: USA

Publications

  1. ncbi Donor risk factors for white blood cell antibodies associated with transfusion-associated acute lung injury: REDS-II leukocyte antibody prevalence study (LAPS)
    Darrell J Triulzi
    Transfusion 47:563-4. 2007
  2. ncbi Detection of anti-D in D- recipients transfused with D+ red blood cells
    Mark H Yazer
    The Institute for Transfusion Medicine and Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    Transfusion 47:2197-201. 2007
  3. ncbi The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia
    Darrell J Triulzi
    University of Pittsburgh and the Institute for Transfusion Medicine, Pittsburgh, PA 15213, USA
    Blood 119:5553-62. 2012
  4. ncbi WBC subset analysis of WBC-reduced platelet components
    D J Triulzi
    Institute for Transfusion Medicine and the Department of Pathology, University of Pittsburgh Medical Center, and the University of Pittsburgh School of Medicine and Graduate School of Public Health, PA 15213, USA
    Transfusion 40:771-80. 2000
  5. ncbi Microchimerism, GVHD, and tolerance in solid organ transplantation
    D J Triulzi
    Department of Pathology, University of Pittsburgh Medical Center and the Institute for Transfusion Medicine, Pittsburgh, PA 15213, USA
    Transfusion 41:419-26. 2001
  6. ncbi Specialized transfusion support for solid organ transplantation
    Darrell J Triulzi
    Department of Pathology, University of Pittsburgh, Pennsylvania, USA
    Curr Opin Hematol 9:527-32. 2002
  7. ncbi Transfusion support in liver transplantation
    Darrell J Triulzi
    Institute for Transfusion Medicine, 3636 Blvd of the Allies, Pittsburgh, PA 15213, USA
    Curr Hematol Rep 3:444-9. 2004
  8. ncbi Transfusion-related acute lung injury: current concepts for the clinician
    Darrell J Triulzi
    Department of Pathology, Division of Transfusion Medicine, University of Pittsburgh Medical Center, Institute for Transfusion Medicine, 3636 Blvd of the Allies, Pittsburgh, PA 15213, USA
    Anesth Analg 108:770-6. 2009
  9. ncbi Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells
    Darrell Triulzi
    Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    Transfusion 46:885-8. 2006
  10. ncbi Detection of HHV-8 (human herpesvirus-8) genomes in induced peripheral blood mononuclear cells (PBMCs) from US blood donors
    L Qu
    Institute for Transfusion Medicine, Pittsburgh, PA 15213, USA
    Vox Sang 100:267-71. 2011

Research Grants

  1. Transfusion Medicine/Hemostasis Clinical Research Network
    Darrell Triulzi; Fiscal Year: 2007

Collaborators

Detail Information

Publications19

  1. ncbi Donor risk factors for white blood cell antibodies associated with transfusion-associated acute lung injury: REDS-II leukocyte antibody prevalence study (LAPS)
    Darrell J Triulzi
    Transfusion 47:563-4. 2007
  2. ncbi Detection of anti-D in D- recipients transfused with D+ red blood cells
    Mark H Yazer
    The Institute for Transfusion Medicine and Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    Transfusion 47:2197-201. 2007
    ..The relatively low sensitization rate in oncology patients transfused with D+ platelets is well documented. A study of the alloimmunization rate of primarily nononcology D- recipients transfused with D+ RBCs was undertaken...
  3. ncbi The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia
    Darrell J Triulzi
    University of Pittsburgh and the Institute for Transfusion Medicine, Pittsburgh, PA 15213, USA
    Blood 119:5553-62. 2012
    ..This trial was registered at www.clinicaltrials.gov as #NCT00128713...
  4. ncbi WBC subset analysis of WBC-reduced platelet components
    D J Triulzi
    Institute for Transfusion Medicine and the Department of Pathology, University of Pittsburgh Medical Center, and the University of Pittsburgh School of Medicine and Graduate School of Public Health, PA 15213, USA
    Transfusion 40:771-80. 2000
    ..Both methods have previously been shown to result in a residual total WBC content <5 x 10(6) per component. However, there may be differences in the efficacy of these techniques for removing certain WBC subsets...
  5. ncbi Microchimerism, GVHD, and tolerance in solid organ transplantation
    D J Triulzi
    Department of Pathology, University of Pittsburgh Medical Center and the Institute for Transfusion Medicine, Pittsburgh, PA 15213, USA
    Transfusion 41:419-26. 2001
    ..The long-term effects of donor HPC infusions on graft survival is under investigation...
  6. ncbi Specialized transfusion support for solid organ transplantation
    Darrell J Triulzi
    Department of Pathology, University of Pittsburgh, Pennsylvania, USA
    Curr Opin Hematol 9:527-32. 2002
    ..The transfusion specialist must recommend the optimal approach to reducing the risk of these complications in organ transplant recipients...
  7. ncbi Transfusion support in liver transplantation
    Darrell J Triulzi
    Institute for Transfusion Medicine, 3636 Blvd of the Allies, Pittsburgh, PA 15213, USA
    Curr Hematol Rep 3:444-9. 2004
    ..The transfusion specialist must recommend the optimal approach to reducing the risk of these complications in liver transplant recipients...
  8. ncbi Transfusion-related acute lung injury: current concepts for the clinician
    Darrell J Triulzi
    Department of Pathology, Division of Transfusion Medicine, University of Pittsburgh Medical Center, Institute for Transfusion Medicine, 3636 Blvd of the Allies, Pittsburgh, PA 15213, USA
    Anesth Analg 108:770-6. 2009
    ..Much more research is needed to understand the blood component and patient risk factors for TRALI so that novel strategies for treatment and additional measures to reduce the risk of TRALI can be developed...
  9. ncbi Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells
    Darrell Triulzi
    Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    Transfusion 46:885-8. 2006
    ..Transfusion-associated graft-versus-host disease (TAGVHD) is a lethal complication of transfusion of nonirradiated cellular blood components to a susceptible recipient...
  10. ncbi Detection of HHV-8 (human herpesvirus-8) genomes in induced peripheral blood mononuclear cells (PBMCs) from US blood donors
    L Qu
    Institute for Transfusion Medicine, Pittsburgh, PA 15213, USA
    Vox Sang 100:267-71. 2011
    ..The prevalence of viral genomes in induced/cultured PBMCs from healthy blood donors has not been systematically studied...
  11. ncbi The cost-effectiveness of reducing donor exposures with single-donor versus pooled random-donor platelets
    I Lopez-Plaza
    Transfusion Service, University of Pittsburgh School of Medicine, and the Central Blood Bank, The Institute For Transfusion Medicine, Pennsylvania, USA
    Transfusion 39:925-32. 1999
    ..Health care reform pressures of make it appropriate to examine the cost-effectiveness of SDPs versus RDPs in reducing donor exposures...
  12. ncbi ABO-mismatched transfusions are not over-represented in febrile non-haemolytic transfusion reactions to platelets
    M H Yazer
    The Institute For Transfusion Medicine, Pittsburgh, PA, USA
    Vox Sang 102:175-7. 2012
    ..ABO-mismatched PLT transfusions do not appear to be aetiological agents of FNHTR in a population routinely receiving both ABO-identical and ABO-mismatched transfusions...
  13. ncbi Stability of lymphocytes and Epstein-Barr virus during red blood cell storage
    L Qu
    Institute for Transfusion Medicine, 3636 Boulevard of the Allies, Pittsburgh, PA 15213, USA
    Vox Sang 92:125-9. 2007
    ..Lymphocytes remain viable during red blood cell (RBC) storage. The effect of RBC storage on the stability of EBV-infected B lymphocytes and EBV genome is not known...
  14. ncbi Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation
    NILAM S MANGALMURTI
    Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, PA 15213, USA
    Blood 113:1158-66. 2009
    ..Thus, reduction in erythrocyte chemokine scavenging is one functional consequence of the storage lesion by which RBC transfusion can augment existing lung inflammation...
  15. ncbi Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation
    Mark H Yazer
    Division of Transfusion Medicine, Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
    Curr Opin Hematol 14:664-70. 2007
    ..Limitations in donor availability for stem cell or organ transplantation require that ABO-incompatible donors be used. Crossing ABO lines can have immune consequences characterized by immediate or delayed hemolysis...
  16. ncbi Use of a pH meter for bacterial screening of whole blood platelets
    Mark H Yazer
    Institute for Transfusion Medicine and Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    Transfusion 45:1133-7. 2005
    ..The use of pH screening of whole-blood PLTs (WBPs) was evaluated with a pH meter at the time of issue as a surrogate test for bacterial contamination...
  17. ncbi Leukoreduction in the setting of open heart surgery: a prospective cohort-controlled study
    Mark K Fung
    Department of Pathology, University of Pittsburgh School of Medicine, USA
    Transfusion 44:30-5. 2004
    ..The mechanisms through which these changes in clinical outcomes are generated remain unknown...
  18. ncbi Clinical effects of reverting from leukoreduced to nonleukoreduced blood in cardiac surgery
    Mark K Fung
    Department of Pathology, University of Vermont, Burlington, VT, USA
    Transfusion 46:386-91. 2006
    ..Follow-up data are now presented in a similar population after a 12-month period in which LR blood was no longer routinely used...
  19. ncbi The art of plasma transfusion therapy
    Darrell J Triulzi
    Transfusion 46:1268-70. 2006

Research Grants1

  1. Transfusion Medicine/Hemostasis Clinical Research Network
    Darrell Triulzi; Fiscal Year: 2007
    ..university of pittsburgh critiques ..